These data demonstrate that disrupting the Aβo-PrPC-mGluR5 pathway at two different steps rescues AD phenotypes, primarily through neuronal expression changes and with modulation of neuronal-glial interactions via C1q. This evidence concerns the gene PRNP and Alzheimer disease.